Functional drug-releasing polymer nano-composites for preventing medical device infection and encrustation

通过开发生产功能生物材料的新方法，这项研究将使澳大利亚受益，因为我们将继续保持我们在该研究领域的领先地位，并通过向美国和欧洲的主要用户群体开发和出口材料技术产生经济效益。凭借我们与CSIRO和昆士兰大学的澳大利亚生物材料开发商以及参与聚氨酯医疗设备商业化的公司(Aortech P/L)的密切联系，该团队处于有利地位，一旦早期基础阶段完成，将在更实用的水平上继续进行研究。

By developing new methodologies for producing functional biomaterials, this research will benefit Australia by continuing our high profile in this research field and by producing economic benefits arising from development and export of materials technologies to the major user groups in USA and Europe. With our demonstrated linkages with Australian based biomaterials developers at CSIRO and University of Queensland, as well as with companies involved in the commercialisation of polyurethane based medical devices (Aortech P/L), this group is well placed to continue the research at a more applied level once the early basic stage is complete.